Particle.news
Download on the App Store
3 ARTICLES
·
last wk.

Bayer Reports 35% Profit Decline as Agricultural Weakness Persists

Despite falling earnings and ongoing litigation costs, Bayer reaffirms its annual forecast and sees pharmaceutical growth as a key driver.

Image
Image

Overview

  • Bayer's Q1 2025 net profit dropped 35% to €1.3 billion, with EBITDA declining 7.4% to €4.1 billion.
  • Agricultural segment revenue fell 3.3% to €7.6 billion, driven by lower performance in seed and crop traits.
  • Pharmaceutical revenue grew 4.1% to €4.5 billion, bolstered by strong sales of Nubeqa and Kerendia.
  • The company allocated $5.9 billion for 67,000 pending glyphosate lawsuits and announced closures at Frankfurt and Dormagen, impacting 1,700 jobs by 2028.
  • Bayer's shares rose over 11% intraday, reflecting investor confidence in its reaffirmed annual guidance despite external uncertainties.